Santhera Pharmaceuticals Holding AG (SPHDF)
OTCMKTS · Delayed Price · Currency is USD
18.40
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
SPHDF Market Cap
SPHDF has a market cap or net worth of $234.70 million as of August 22, 2025. Its market cap has increased by 100.01% in one year.
Market Cap
234.70M
Enterprise Value
234.32M
Revenue
43.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$18.40
Market Cap Chart
Since November 3, 2006, SPHDF's market cap has decreased from 284.68M to 234.70M, a decrease of -17.55%. That is a compound annual growth rate of -1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 228.82M | 24.05% |
| Dec 30, 2024 | 184.46M | 71.97% |
| Dec 29, 2023 | 107.26M | 31.69% |
| Dec 30, 2022 | 81.45M | 33.38% |
| Dec 30, 2021 | 61.07M | 0.06% |
| Dec 30, 2020 | 61.03M | -53.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |